223 related articles for article (PubMed ID: 12579598)
1. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
Ulanet DB; Wigley FM; Gelber AC; Rosen A
Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
[TBL] [Abstract][Full Text] [Related]
2. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
4. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
5. Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: insights into the association of specific autoantibodies with distinct disease phenotypes.
Ulanet DB; Flavahan NA; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2004 Jan; 50(1):233-41. PubMed ID: 14730621
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
Reimer G
Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
8. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
Negi VS; Tripathy NK; Misra R; Nityanand S
J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
[TBL] [Abstract][Full Text] [Related]
9. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
[TBL] [Abstract][Full Text] [Related]
12. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma.
Wusirika R; Ferri C; Marin M; Knight DA; Waldman WJ; Ross P; Magro CM
Am J Clin Pathol; 2003 Oct; 120(4):596-606. PubMed ID: 14560571
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
Hasegawa M; Sato S; Yanaba K; Komura K; Yamazaki M; Takehara K
Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
[TBL] [Abstract][Full Text] [Related]
14. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
15. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
[TBL] [Abstract][Full Text] [Related]
16. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M
J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663
[TBL] [Abstract][Full Text] [Related]
17. [Serology in patients with scleroderma].
Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A
Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453
[TBL] [Abstract][Full Text] [Related]
18. Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis.
Overzet K; Gensler TJ; Kim SJ; Geiger ME; van Venrooij WJ; Pollard KM; Anderson P; Utz PJ
Arthritis Rheum; 2000 Jun; 43(6):1327-36. PubMed ID: 10857791
[TBL] [Abstract][Full Text] [Related]
19. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]